Biocad bringing biosimilars to North Africa through fill/finish plant
Biocad has partnered with Sothema to make biosimilars in North Africa, which it says will boost access to biologics for ‘less affluent’ patients.
Archives for December 8, 2017
Three for Friday: Facility news from CSL, Kiadis and ADC Bio
CSL opens a $173m albumin plant in Australia, Kiadis leases a facility in The Netherlands, and ADC Bio signs a construction agreement in Wales. Welcome to Biopharma-Reporter’s facility round-up.
Business as usual at Amgen following voluntary evacuation at Cali site
Wildland fires prompted staff to evacuate Amgen’s Thousand Oaks campus on Tuesday in California, US.
Gilead buying Cell Design Labs for $567m in further CAR T boost
Months after jumping into the cell therapy space through the $11.9bn acquisition of Kite, Gilead has agreed to buy CAR T tech firm Cell Design Labs.